SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development
The pandemic of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been posing great threats to the world in many aspects. Effective therapeutic and preventive approaches including drugs and vaccines are still unavailable although they are in development. Comprehensive unders...
Main Authors: | Mei-Yue Wang, Rong Zhao, Li-Juan Gao, Xue-Fei Gao, De-Ping Wang, Ji-Min Cao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2020.587269/full |
Similar Items
-
Aprotinin Inhibits SARS-CoV-2 Replication
by: Denisa Bojkova, et al.
Published: (2020-10-01) -
Antiviral Activity of Micafungin and Its Derivatives against SARS-CoV-2 RNA Replication
by: Shogo Nakajima, et al.
Published: (2023-02-01) -
Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro
by: Finny S. Varghese, et al.
Published: (2021-02-01) -
Seroprevalence of SARS-CoV-2 Among Children Visiting a Tertiary Hospital in Himachal Pradesh, India
by: Pancham Kumar, et al.
Published: (2023-01-01) -
Differential Tropism of SARS-CoV and SARS-CoV-2 in Bat Cells
by: Susanna K.P. Lau, et al.
Published: (2020-12-01)